{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-027816","form_type":"8-K","ticker":"PRME","cik":"0001894562","company_name":"Prime Medicine, Inc.","filed_at":"2024-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.124806+00:00","generated_at":"2026-06-01T04:55:38.848330+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Prime Medicine stockholders elect directors, approve officer liability limitation","bullets":["Stockholders elected Wendy Chung, Kaye Foster, Keith Gottesdiener, and Jeffrey Marrazzo as Class II directors.","Approved certificate amendment to limit officer liability as permitted by Delaware law with 91.5M votes for.","Ratified PricewaterhouseCoopers as independent auditor for FY2024 with 106.9M votes for.","Annual meeting held June 12, 2024; quorum of 107.1M shares represented.","All proposals passed; no dissident activity or unexpected vote outcomes."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-027816","json":"https://secwatch.observer/filing/0001628280-24-027816.json","markdown":"https://secwatch.observer/filing/0001628280-24-027816.md","text":"https://secwatch.observer/filing/0001628280-24-027816.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1894562/000162828024027816/0001628280-24-027816-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1894562/000162828024027816/prme-20240612.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:55:38.848330+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}